ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2023

Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.

Barry A Singer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.